Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Annual Information Update

1 Apr 2011 09:20

Annual Information Update for Chesnara plc

In accordance with section 5.2 of the FSA Prospectus Rules, this Update provides a description of all the information made public by Chesnara plc in the period 1 January 2010 to 31 December 2010.

The information referred to was correct at the time of publication but may now be out of date.

1. Announcements made via a Regulatory Information Service

All the information referred to in this update can be viewed in the Financial Information section of our website at www.chesnara.co.uk

Date of Publication Headline Short Description

08 March 2010 Notice of Results Notice of Results 31 March 2010 Final Results Final Results year to 31 December 2009 1 April 2010 Annual Description of all information made Information public by Chesnara plc in 2009 Update 27 April 2010 Annual Financial Additional Regulated information Report 13 May 2010 Result of AGM Voting Results from AGM 19 May 2010 Interim Interim Management Statement for first Management quarter 2010 Statement 18 June 2010 Price Monitoring Price Monitoring Extension Extension 11 August 2010 Notice of Results Notice of Interim Results Announcement. 26 August 2010 Half-yearly Interim Results for half year to 30 June Report 2010

28 September 2010 Holding(s) in Ameriprise Group Inc and its group Company interest in 11,210,987 Ordinary 5p shares 19 November 2010 Interim Interim Management Statement for third Management quarter 2010 Statement 26 November 2010 Acquisition Proposed Acquisition of Save & Prosper Insurance Limited 26 November 2010 Result of Placing Result of Placing of 10.458,877 new ordinary 5p shares 30 November 2010 Statement re: Posting of Circular to Shareholders Posting of Circular to Shareholders 1 December 2010 Holding(s) in Total Voting Rights increased to Company 114,848,651 1 December 2010 Holding(s) in Norges Group interest in 3,893,220 Company Ordinary 5p shares 06 December 2010 Holding(s) in Ameriprise Group Inc and its group Company interest in 12,581,627 Ordinary 5p shares 07 December 2010 Holding(s) in Ameriprise Group Inc and its group Company interest in 12,642,746 Ordinary 5p shares 16 December 2010 Result of GM Voting Results from GM 17 December 2010 Price Monitoring Price Monitoring Extension Extension 17 December 2010 Second Price Price Monitoring Extension Monitoring Extension 20 December 2010 Acquisition Completion of Acquisition of Save & Prosper Insurance Limited

2. Documents Filed at Companies House

The company has submitted filings at Companies House:

* Special Resolutions passed at the AGM.

Details of these can be found on the Companies House website at www.companieshouse.com

3. Annual and Interim Financial Statements

The company's annual Report and Accounts for the year ended 31 December 2009 and the 2010 Interim Financial Statements are available on the company's website at www.chesnara.co.uk

vendor
Date   Source Headline
24th Oct 20227:00 amRNSBlock listing Interim Review
19th Oct 20227:00 amRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAppointment of Group GC & Company Secretary
29th Sep 20227:00 amRNSBlock Listing Application
12th Sep 20227:15 amEQSHardman & Co Research on Chesnara Plc (CSN): Robust cash generation in challenging markets
8th Sep 202212:05 pmEQSHardman Talks Video: Interview Chesnara management discuss 2022 half-year results
2nd Sep 20227:00 amRNSHolding(s) in Company
31st Aug 20227:00 amRNSHalf-year Report
23rd Aug 20227:00 amRNSHolding(s) in Company
17th Aug 20227:00 amRNSNotice of Interim Results
15th Aug 20222:45 pmEQSHardman & Co: Q&A on Chesnara Plc (CSN) Conservatrix acquisition boosts AuA and cash flow with capacity for more
8th Aug 20227:00 amRNSHolding(s) in Company
5th Aug 20227:00 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSChesnara Enhances M&A and Commercial Capabilities
29th Jul 20227:15 amEQSHardman & Co Research: Chesnara plc (CSN): Another fine acquisition
22nd Jul 20227:00 amRNSAcquisition
16th Jun 20229:15 amEQSHardman & Co Research: Q&A on Chesnara Plc (CSN): Good performance analysed
31st May 20227:00 amRNSTotal Voting Rights
24th May 20227:00 amEQSHardman & Co Research : Chesnara plc (CSN): Market benefits overwhelm operational challenges
17th May 20221:51 pmRNSResult of AGM
29th Apr 20227:00 amRNSDirector/PDMR Shareholding
28th Apr 20227:00 amRNSAcquisition Completions
22nd Apr 20227:00 amRNSBlock listing Interim Review
21st Apr 20227:00 amRNSNotice of AGM
8th Apr 20227:00 amRNSAcquisition Update
5th Apr 20222:30 pmRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSFinal Results
17th Mar 20227:00 amRNSNotice of Results
15th Mar 20227:00 amRNSTotal Voting Rights
14th Feb 20227:00 amRNSDirectorate Change
2nd Feb 20223:07 pmRNS£200m Inaugural Tier 2 Subordinated Notes Issuance
26th Jan 20227:00 amRNSHolding(s) in Company
17th Jan 20227:00 amRNSDirectorate Change
17th Dec 20217:00 amRNSSenior Leadership Appointment
9th Dec 20217:00 amRNSHolding(s) in Company
2nd Dec 20211:50 pmEQSHardman & Co Research : Chesnara (CSN) Initiation of Coverage: Could be the least worrying dividend you'll get
26th Nov 20211:00 pmRNSDirector/PDMR Shareholding
25th Nov 20217:00 amRNSAcquisition
22nd Oct 20217:00 amRNSBlock listing Interim Review
19th Oct 20217:00 amRNSDirectorate Change
13th Sep 20217:00 amRNSProposed Acquisition
7th Sep 20217:00 amRNSHolding(s) in Company
26th Aug 20217:00 amRNSHalf-year Report
12th Aug 20217:00 amRNSNotice of Results
2nd Aug 20217:00 amRNSDirectorate Change
28th May 20214:36 pmRNSHolding(s) in Company
28th May 20217:00 amRNSTotal Voting Rights
21st May 20217:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
18th May 20213:30 pmRNSResult of AGM
12th May 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.